Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa open-label study of inhaled H057 in mild to moderate acute respiratory distress syndrome
CTR20243201Phase 2Active
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H-057 in acute respiratory distress syndrome (ARDS), sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started Aug 2024; status: active.
02
Drugs
H-057
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on CTR20243201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243201.